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SECTION I: USE OF THE CLINICAL PRACTICE GUIDELINE
This Clinical Practice Guideline document is based upon systematic literature searches last
conducted in June 2011, supplemented with additional evidence through November 2012. It is
designed to provide information and assist decision making. It is not intended to define a
standard of care, and should not be construed as one, nor should it be interpreted as prescribing
an exclusive course of management. Variations in practice will inevitably and appropriately occur
when clinicians take into account the needs of individual patients, available resources, and
limitations unique to an institution or type of practice. Every health-care professional making
use of these recommendations is responsible for evaluating the appropriateness of applying them
in any particular clinical situation. The recommendations for research contained within this
document are general and do not imply a specific protocol.
SECTION II: DISCLOSURE
Kidney Disease: Improving Global Outcomes (KDIGO) makes every effort to avoid any actual or
reasonably perceived conflicts of interest that may arise as a result of an outside relationship or a
personal, professional, or business interest of a member of the Work Group. All members of the
Work Group are required to complete, sign, and submit a disclosure and attestation form
showing all such relationships that might be perceived as or are actual conflicts of interest. This
document is updated annually and information is adjusted accordingly. All reported information
is published in its entirety at the end of this document in the Work Group members’ Biographic
and Disclosure Information section, and is kept on file at the National Kidney Foundation
(NKF), former Managing Agent for KDIGO.
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Single photocopies may be made for personal use as allowed by national copyright
laws. Special rates are available for educational institutions that wish to make photocopies
for non-profit educational use. No part of this publication may be reproduced, amended, or
transmitted in any form or by any means, electronic or mechanical, including photocopying,
recording, or any information storage and retrieval system, without explicit permission in
writing from KDIGO. Details on how to seek permission for reproduction or translation,
and further information about KDIGO’s permissions policies can be obtained by contacting
Danielle Green, Managing Director, at danielle.green@kdigo.org
To the fullest extent of the law, neither KDIGO, Kidney International Supplements, National
Kidney Foundation (KDIGO’s former Managing Agent) nor the authors, contributors, or
editors, assume any liability for any injury and/or damage to persons or property as a matter
of products liability, negligence or otherwise, or from any use or operation of any methods,
products, instructions, or ideas contained in the material herein.
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